DRVISION TECHNOLOGIES LLC

Bellevue, WA · Biotech · Defunct

Intelligent connectomic analysis software tool for automated detection, classification, and tracing of neurons and synapses in electron microscopy and fluorescence microscopy data

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · drvtechnologies.com

Sector: Biotech
Headquarters: Bellevue, WA
Total capital: $7.8M

Federal grants: $7.7M; 10 awards · 2015–2020; Rank in peer group#9 of 19
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $144K; 5 awards · Veterans Affairs, Health and Human S; Rank in Biotech#311 of 4373
Granted patents: 7; 1 pending · first 2015; Rank in peer group#2 of 19

Capital timeline

Latest events

Aug 2020Federal contractHealth and Human S · Aivia Core Performing 2D/3D And 2D/3D Time-lapse Image Analysis$18K
Aug 2020Federal contractHealth and Human S · Drvision Technologies LLC:1186688 [20-009264]$18K
Jul 2020Federal grantHealth and Human S · Phase II · Intelligent connectomic analysis tool for dense neuronal circuits$1M
Jun 2020Federal grantHealth and Human S · Phase II · Intelligent connectomic analysis tool for dense neuronal circuits$330K
Jun 2020Federal contractHealth and Human S · Light Microscopy Core Requires Aivia 2D/3D Image Analysis Software In Order To Perform 2D/3D Time-lapse Image Analysis.$18K
May 2020Federal contractHealth and Human S · Aivia Cf-pro Software License$35K
Apr 2020Federal grantHealth and Human S · Phase I · AI platform for microscopy image restoration and virtual staining$287K

Show 8 earlier federal awards

Sep 2019Federal grantHealth and Human S · Phase II · Kinetic Phenotype Discovery Informatics for Neurological Diseases$602K
Jun 2019Federal grantHealth and Human S · Phase II · Intelligent connectomic analysis tool for dense neuronal circuits$251K
Sep 2018Federal contractVeterans Affairs · Avia - Cf Pro Complete Package For Microscopy Facilities 2D/3D And Electron Microscopy Unique Image Analysis.$55K
Aug 2018Federal grantHealth and Human S · Phase II · Kinetic Phenotype Discovery Informatics for Neurological Diseases$957K
Sep 2017Federal grantHealth and Human S · Phase II · Kinetic Phenotype Discovery Informatics for Neurological Diseases$2.8M
Aug 2017Federal grantHealth and Human S · Phase II · Kinetic Phenotype Discovery Informatics for Neurological Diseases$906K
Aug 2016Federal grantHealth and Human S · Phase II · Kinetic Phenotype Discovery Informatics for Neurological Diseases$218K
Aug 2015Federal grantHealth and Human S · Phase I · A 3D particle tracking tool for next generation neuroscience microscopy$292K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 19 peers

Line = median

Biotech · Software

Federal grants#9 · top 47%
Granted patents#2 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 7 granted of 8

Jan 12, 2021GrantedOptimal And Efficient Machine Learning Method For Deep Semantic SegmentationUSPTOUS 10,891,523
Sep 8, 2020GrantedAutomated Parameterization Image Pattern Recognition MethodUSPTOUS 10,769,432
Jul 21, 2020GrantedEfficient Machine Learning MethodUSPTOUS 10,719,780

Show all 8 patent records

Optimal And Efficient Machine Learning Method For Deep Semantic SegmentationJan 12, 2021 · US 10,891,523Granted
Automated Parameterization Image Pattern Recognition MethodSep 8, 2020 · US 10,769,432Granted
Efficient Machine Learning MethodJul 21, 2020 · US 10,719,780Granted
Optimal And Efficient Machine Learning Method For Deep Semantic SegmentationJun 23, 2020 · US 10,691,978Granted
Edit Guided Processing Method For Time-lapse Image AnalysisMar 15, 2016 · US 9,286,681Granted
Recipe Based Method For Time-lapse Image AnalysisNov 24, 2015 · US 9,196,038Granted
Image Guided Protocol For Cell GenerationNov 3, 2015 · US 9,173,909Granted
Interactive Object And Track Array Based Image Analysis MethodJul 16, 2015 · Application 14156436Pending

EVAS THERAPEUTICS LLCSimilar federal contract value in Biotech · $150K in contracts
RESPIRERX PHARMACEUTICALS INC.Similar federal contract value in Biotech · $149K in contracts
PROTEIN METRICS INCSimilar federal contract value in Biotech · $147K in contracts
28bio, Inc.Similar federal contract value in Biotech · $143K in contracts
HAGER BIOSCIENCES, LLCSimilar federal contract value in Biotech · $142K in contracts
INSMED INCSimilar federal contract value in Biotech · $139K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.